Skip to main content
Immunovia logo

Immunovia — Investor Relations & Filings

Ticker · IMMNOV ISIN · SE0006091997 LEI · 549300KHWL6KK1XGUO81 ST Human health and social work activities
Filings indexed 378 across all filing types
Latest filing 2024-10-03 Annual Report (ESEF)
Country SE Sweden
Listing ST IMMNOV

About Immunovia

https://immunovia.com/

Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 100% confidence FY 2023
2024-10-03 Swedish
Change in number of shares and votes in Immunovia AB (publ)
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing a change in the total number of shares and votes in Immunovia AB due to a rights issue and a directed issue of units. This type of announcement, which details changes in share capital and voting rights, falls under the category of share issues and capital changes.
2024-09-30 English
Ändring av antalet aktier och röster i Immunovia AB (publ)
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Immunovia AB announcing a change in the total number of shares and votes following a rights issue and a directed share issue. This type of disclosure regarding changes in share capital is classified under 'Share Issue/Capital Change' (SHA) as it specifically details the increase in the number of registered shares and votes.
2024-09-30 Swedish
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding for Immunovia AB, where Avanza Bank Holding AB has crossed a 10% ownership threshold due to a new share issue. This is a classic major shareholding notification, which falls under the 'Major Shareholding Notification' category.
2024-09-26 Swedish
Immunovia carries out a directed issue of units to guarantors in connection with the completed rights issue
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Immunovia AB announcing a 'directed issue of units' to guarantors as compensation for a previously completed rights issue. It details the number of shares, warrants, subscription prices, and the impact on share capital and dilution. This falls under the category of share issuance and capital structure changes, specifically related to the company's own shares and capital adjustments.
2024-09-12 English
Immunovia genomför en riktad emission av units till garanter i samband med den genomförda företrädesemissionen
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Immunovia AB announcing a 'directed issue of units' (a form of share issuance) to guarantors as compensation for their role in a previous rights issue. It details the number of units, subscription price, dilution effects, and the rationale for the issuance. This falls under the category of share issuance and capital changes, which is classified as 'SHA'.
2024-09-12 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.